Message from the Editor
Editor-in-chief Debu Tripathy comments on the Summer issue of CURE.
Genetics Leading the Way in Lung Cancer Treatment
CURE editor-in-chief Debu Tripathy introduces readers to the CURE Spring 2014 issue.
Letter From the Editor: Paying for Cancer Care
CURE's editor addresses the high cost of cancer care.
Message From the Editor
Pancreatic cancer as a paradigm.
Dispatch: Society for Integrative Oncology's 10th Annual Meeting
Researchers gathered for the 10th annual meeting of the Society for Integrative Oncology.
Supreme Court Votes Against Human Gene Patents
The U.S. Supreme Court decides against patents on human genes.
What does personalized medicine actually mean?
Think about the long-term consequences of cancer treatment.
Do Two Bads Equal One Good?
The number of cancers and scenarios to respond to chemoradiation therapy has grown.
Adherence to oral anticancer medication—a report card.
New Options for Colorectal Cancer
There are now more options for treating advanced colorectal cancer.
Becoming an effective partner in managing metastatic cancer.
Hormone therapy for breast cancer: built on success.
Shifts in Causation, Biology and Treatment of Head and Neck Cancer
Editor Debu Tripathy, MD, explains the shifts in causation, biology and treatment of head and neck cancer.
Despite Advances, More Work is Needed in Bladder Cancer
Editor Debu Tripathy, MD, highlights the need for new treatments needed for bladder cancer and other stories in CURE.
Managing Cancer Treatment Side Effects
New Research, Discoveries in Hodgkin Lymphoma
New research, discoveries in Hodgkin lymphoma
The Meaning of Stem Cells
The term “stem cells” has taken on a scientific, political and conversational context over the past few years for many reasons.
What is the Benefit, Precisely?
We are retooling clinical trials, but are not sure that this will all work quite yet.
Editor's Page
New directions in surgery, treatment and reconstruction are changing breast cancer.
The right journalism for the right audience.
Personalizing the intangibles: mindfulness as a common path
Clinical trial enrollment, and why it matters to all of us.
Cancer Vaccines No Longer a Long Shot
Spring 2010 Letter from the Editor
Minorities and Cancer: A Lesson for Us All
Why issues that impact minorites with cancer affect everyone.
The relationship between a tumor and the surrounding environment is complex, with each influencing the other.
Web Exclusive: When is Multidisciplinary Care Really Needed?
Every cancer case or medical decision may not require a multidisciplinary team, but here are some signs that may help you decide.
A positive turn of events for a "negative" tumor.
Web Exclusive: Solving a Medical Mystery
Cancer is usually not an emergency, so days or even weeks should be taken to answer the question as best possible.
Have targeted therapies lived up to our expectations?